2Lindskog A, Ebefors K, Johansson ME, et al. Melanocortin 1 receptor agonists reduce proteinuria [ J ] . J Am Soc Nephrol, 2010,21 (8) :1290-1298.
3Bech AP, Hofstra JM, Brenchley PE, et al. Association of anti- PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy [ J ]. Clin J Am Soc Nephrol,2014,9 ( 8 ) : 1386-1392.
4Saito T, Iwano M, Matsumoto K,et al. Significance of combined cy- closporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial [ J ]. Clin Exp Nephrol, 2014,18 ( 5 ) : 784-794.
5Heymann W, Hackel DB, Harwood S,et al. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions [J]. Proc Soe Exp Biol Med,1959,100(4) :660-664.
6Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis) [J]. J Am Soc Nephrol,1996,7(12) :2518-2526.
7Borza DB, Zhang J J, Beck LH,et al. Mouse models of membranous nephropathy: the road less travelled by [ J ]. Am J Clin Exp Immunol,2013,2(2) :135-145.
8Debiec H, Guigouis V, Mougenot B, et al. Antenatal membranous glomemlonephritis due to anti-neutral endopeptidase antibodies [ J]. N Engl J Med,2002,346(26) :2053-2060.
9Debiee H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonepbritis with vascular injury induced by anti-neutral en- dopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases [ J ]. J Am SoeNephrol, 2003, 14 Suppl 1 : S27-32.
10Debiec H, Nauta J, Coulet F,et al. Role of truncating mutations in MME gene in sation and antenatal glomer- ulopathies [ J]. Lancet ,2004,364(9441 ) :1252-1259.
